Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Biogen, Sage
Sage rejects Biogen's $469 million takeover offer
Sage Therapeutics said on Monday that its board has unanimously rejected the takeover offer it received from Biogen. The company said Biogen's offer to buy all outstanding shares of Sage that it does not already own for $7.
Sage Rejects Biogen’s Unsolicited Offer, Will Seek Strategic Alternatives
Following a lawsuit filed last week, Sage has officially rejected Biogen’s unsolicited buyout offer, which valued the embattled biotech at just $469 million.
Sage rejects Biogen’s buyout offer, but says it's open to deals
Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen Inc.
Sage Rejects Biogen’s Takeover Offer, Will Explore Options
Sage Therapeutics Inc. rejected a takeover offer from drugmaker Biogen Inc. and said it has started exploring possible options including a sale.
Sage Sues Partner Biogen After Unsolicited Takeover Offer
Biogen’s effort to buy Sage reveals its “desire to expand its pipeline at a discount,” according to analysts from BMO Capital Markets.
Sage rejects Biogen's $469 million takeover offer, says offer undervalues company
Sage Therapeutics said on Monday that its board has unanimously rejected Biogen’s $469 million offer, stating it "significantly undervalues" the company and does not serve shareholders' best interests.
Sage Rejects Biogen Bid, Launches Review of Alternatives
Sage Therapeutics has rejected a buyout bid from partner Biogen and launched a review of strategic alternatives. Sage on Monday said its board determined that Biogen's $7.22-a-share proposal significantly undervalues the biopharmaceutical company and isn't in the best interest of its shareholders.
Sage Therapeutics rejects Biogen bid, starts strategic review
Sage Therapeutics rejected a takeover offer from Biogen and said it started a process to review its strategic alternatives. Sage rose 5.6%. Sage's board will look at
7m
Sage Group falls Monday, underperforms market
Sage Group PLC SGE shares inched down 0.34% to £13.26 Monday, on what proved to be an all-around favorable trading session ...
FiercePharma
6d
Sage sues Biogen as analyst detects little interest in buyout at original offer price
Sage Therapeutics has brought a lawsuit against Biogen shortly after receiving an “unsolicited” offer from its neuroscience ...
bovnews
2h
Why Did SAGE Therapeutics Inc (SAGE) Stock Surge 1.87% Last Week?
SAGE Therapeutics Inc (SAGE) stock saw a modest uptick, ending the day at $7.1 which represents a slight increase of $0.08 or 1.14% from the prior close of $7.02. The stock opened at $7.02 and touched ...
11d
How to Harvest Sage for a Continuous Supply of Delicious Herbs, According to Gardening Experts
To store fresh sage, wrap it in a damp paper towel, place it in a plastic bag or container, and store it in the refrigerator ...
5d
Sage Therapeutics: Looks Like A 'Strong Buy' With Zurzuvae's Potential And Biogen's Bid
Sage Therapeutics has a unique approach to targeting GABA, which allows it to target CNS disorders. Read why I think SAGE ...
2d
on MSN
‘Recalibrated’ Sage Hill girls basketball races past Portola to extend winning streak
Amalia Holguin, Addison Uphoff and Kamdyn Klamberg combine for 47 points as Sage Hill wins its sixth straight game.
TheGamer on MSN
3d
Guide To Playing Sage In PvP In FFXIV
While you don't have all the multitude of skills Sage has in PvE, the core concept of the job is maintained in PvP. Although ...
Hosted on MSN
2d
Sage Group Undertakes Share Buyback to Boost Shareholder Value
Sage Group plc ( ($GB:SGE) ) has issued an update. Sage Group plc has repurchased 389,944 of its ordinary shares as part of a share buyback ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback